CELLSIGHT TECHNOLOGIES, INC.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cellsighttech.com
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06107374
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Test-retest Evaluation of [18F]F-AraG PET
- Conditions
- Non-small Cell Lung Cancer
- Interventions
- Drug: [18F]F-ARAG PET
- First Posted Date
- 2023-10-16
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06084806
- Locations
- 🇺🇸
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Imaging Immune Activation in COVID-19
- Conditions
- SARS-CoV InfectionCovid19
- Interventions
- Drug: [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)
- First Posted Date
- 2021-03-24
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT04815096
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2021-01-27
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT04726215
- Locations
- 🇺🇸
Sutter Cancer Center, Sacramento, California, United States
🇺🇸Palo Alto Veterans Institute of Research, Palo Alto, California, United States
🇺🇸Stony Brook University, Stony Brook, New York, United States
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
- Conditions
- Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04260256
- Locations
- 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
🇺🇸Stanford University, Stanford, California, United States
Imaging Immune Activation in HIV by PET-MR
- Conditions
- HIV Infections
- Interventions
- Drug: [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)
- First Posted Date
- 2018-09-26
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03684655
- Locations
- 🇺🇸
University of California, San Francisco, San Francisco, California, United States
Detection of Graft Versus Host Disease With [18F]F-AraG
- Conditions
- Graft Versus Host Disease
- Interventions
- Drug: [18F]F-Ara-G
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03367962
- Locations
- 🇺🇸
Stanford Hospital, Stanford, California, United States
[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy and/or Radiation Therapy
- Conditions
- Cancer
- First Posted Date
- 2017-05-05
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03142204
- Locations
- 🇺🇸
UCSF Imaging Center at China Basin, San Francisco, California, United States
Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
- Conditions
- Squamous Cell Carcinoma of the Head and Neck
- Interventions
- Drug: [18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.
- First Posted Date
- 2017-04-26
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03129061
- Locations
- 🇺🇸
Stanford Hospital and Clinics, Stanford, California, United States
Study of Kinetics, Dosimetry & Safety of [18F]F-AraG, a Positron Emission Tomography Imaging Tracer in Healthy Humans
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2018-05-17
- Lead Sponsor
- CellSight Technologies, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT02323893
- Locations
- 🇺🇸
UCSF Imaging Center at China Basin, San Francisco, California, United States